Office of the Executive Secretariat Leadership
Lydia Vogt, Acting Executive Secretariat Director
As Acting Director of the Office of the Executive Secretariat, Lydia manages information flows throughout the agency - designing efficient informational pathways and implementing complex cross-agency projects, in addition to maintaining systems to monitor progress and identify operational challenges. Lydia also oversees the development of comprehensive briefing materials, executive correspondence, and high-level reports to support informed decision-making – in addition to ensuring timely and accurate communication between the FDA and key stakeholders, including HHS and the White House. She further provides strategic guidance to the FDA Commissioner and senior leadership on policy, agency-wide initiatives, decisions, and priorities.
Prior to joining FDA, Lydia served as a Global People Strategy Leader at International Justice Mission, the world's largest human rights organization fighting to protect vulnerable populations from violence. She brings extensive experience leading people programs, implementing enterprise technology solutions, and transforming operations to enhance organizational effectiveness and customer experience. She studied Theology at Northland International University and her intellectual curiosity underscores each endeavor
Lydia's leadership style is collaborative, decisive, and mission-driven, grounded in empathy and a commitment to excellence. She excels at cultivating engaged teams and building sustainable systems. Known as a trusted advisor to executives and staff, she brings strategic vision, stakeholder engagement skills, and the ability to chart clear paths to meaningful outcomes.
Daniel Connally, Acting Deputy Director
As Acting Deputy Director in the Food and Drug Administration's Office of Executive Secretariat, Daniel Connally plays a critical role in supporting the agency's leadership and ensuring effective communication across FDA's centers and offices. The Office of Executive Secretariat serves as the central coordination point for correspondence and information flow to and from the Office of the Commissioner, managing the review and clearance of official agency documents, responses to congressional inquiries, and communications with external stakeholders. In this capacity, Dan oversees the development and implementation of policies and procedures that facilitate timely decision-making, coordinates cross-agency initiatives, and ensures that critical information reaches senior leadership efficiently.
Prior to this role, Dan served as the Acting Director of the Division of Organizational Communication and Engagement (DOCE) within FDA's Office of Inspections and Investigations (OII), where he led strategic communication, web and digital media, public affairs, ombudsman, and executive secretariat functions. As Strategic Communications Staff Director, he oversaw a team of communications specialists and directed initiatives that advanced OII's communication priorities, ensuring consistent and persuasive messaging across FDA stakeholders.
Dan brings extensive experience in strategic planning, cross-agency coordination, and policy advising from key leadership roles across the Department of Health and Human Services, including positions with the Administration for Strategic Preparedness and Response (ASPR), Office of Global Affairs (OGA), and the Assistant Secretary for Planning and Evaluation (ASPE). His diverse background encompasses emergency response, public health preparedness, veteran advocacy, joint multi-year strategic planning with DoD and HHS, and Marine Corps leadership.
Dan earned his undergraduate degree in Public Relations and Advertising from Liberty University and began his career with a non-profit organization, focusing on social media development and video editing as part of comprehensive communications strategies. He also served as Vice President for Communications with the United States Marine Corps Reserve Association, a non-profit military organization advocating for veterans' resources in government.
Yolanda Jenkins, Acting Program Operations Associate Director
Yolanda Jenkins serves as the Acting Program Operations Associate Director in the Office of the Executive Secretariat (OES). In this role, she leads a team of experienced correspondence analysts responsible for managing and overseeing a high volume of incoming documents from the U.S. Department of Health and Human Services and other key stakeholders. These include congressional inquiries, public correspondence, and stakeholder meeting and invitation requests that are addressed, in whole or in part, to the Commissioner. Yolanda’s team ensures the timely coordination, review, and disposition of these materials in support of Agency leadership and mission priorities.
Yolanda began her career at FDA in 2007, starting as a Junior Policy Analyst in OES where she managed FOIA requests and supported Commissioner briefings and meetings. In 2009, Yolanda moved to the Office of Policy as a GAO/OIG Liaison Policy Analyst and then in 2011 as a Project Manager/Policy Analyst for the Communications and Public Engagement Team in the former Office of Foods and Veterinary Medicine within the now Human Foods Program. In 2016, Yolanda returned to OES as a Policy Analyst and covered all aspects of the CDER, HFP, and CVM desks and in 2023, she functioned as the meeting manager and record keeper for the former Principal Deputy Commissioner, supporting over 40 listening sessions with approximately 400 FDA employees on the Human Foods Program reorganization.
Yolanda received a Master of Public Administration from George Mason University and Bachelor of Science in Mass Communications from Virginia Commonwealth University.
Silvia Wanis, OC/OII Staff Director
CDR Silvia Wanis is a Staff Director in the Office of the Executive Secretariat (OES) within the Office of the Commissioner (OC). She has been a PharmD for over 25 years and joined the FDA in 2010 as a Consumer Safety Officer in CDER's Office of Compliance. In that role, she became a subject matter expert in regulatory compliance, ensuring the safety and security of the nation's drug supply and coordinating enforcement actions to mitigate supply chain disruptions and drug shortages of medically necessary medicines. CDR Wanis also worked in CDER's Office of Medical Policy and CBER's Office of Manufacturing and Product Quality.
CDR Wanis joined OC-OES in October 2025 as a Senior Policy Analyst and was promoted to Staff Director in March 2026. In this role, she leads a team of Public Health Program Specialists who facilitate information flow across the FDA and partner with Centers, Offices, and Programs to document information pathways. She manages her team's review, editing, and clearance of high-level documents, including reports to executive agencies, Congressional correspondence, and materials requiring signature by the HHS Secretary or FDA Commissioner. Additionally, she oversees the coordination of briefings and meetings with the Commissioner, senior management, HHS officials, and external stakeholders, and manages responses to data calls from the White House, HHS, and other FDA offices.
Prior to joining the FDA, CDR Wanis was a pediatric pharmacist at the University of Chicago Children's Hospital. She is a Board-Certified Pediatric Pharmacotherapy Specialist and holds a Master's degree in Executive Leadership. She received her PharmD degree from the University of Illinois at Chicago, College of Pharmacy.
Johanna Mclatchy, Acting Medical Products Staff Director
Johanna Mclatchy, RN, BSN, M.Sc. is the former Director of the Executive Operations Staff, Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration, detailed to the Office of Operations, Executive Secretariat where she manages critical correspondence, policy documents and official documents while coordinating information flows between Medical Products Centers and agency components.
Ms. Mclatchy started her career with the FDA as a Commissioned Corps Officer serving in the capacity as a Designated Federal Official responsible for high-profile advisory committees and meetings on issues of public health and drugs of concern. After her tenure in the Commissioned Corps, Ms. McClatchy pivoted to the Drug Enforcement Administration, Diversion Control Division, supporting and providing clinical, enforcement, compliance, and regulatory expertise towards efforts related to policy and drug control in the U.S. and internationally. Shifting her career back to the FDA, Immediate Office of CDER, she served in various roles to oversee the consistent application of policy, regulatory guidance interpretation, enforcement and programmatic support within FDA to provide scientific guidance and technical direction, provide leadership to subordinates and oversight of operations, served as a liaison to the Agency and Department on novel, complex, Center-wide cross cutting issues, all in support of short and long term goals for the Center and Agency.
Ms. Mclatchy holds a Bachelor of Arts and a Bachelor of Science from the University of Maryland and Catholic University of America. She also holds a Master of Science from the University of Maryland. She maintains an active clinical licensure with clinical experience spanning acute care, including emergency and pre/post-op units, as well as specialized oncologic and ambulatory settings.
Stephanie Socgfack, Acting Consumer and Animal Products Staff Director
Stephanie Socgfack serves as the Acting Consumer and Animal Products Staff Director in the Office of the Executive Secretariat (OES). In this role, she supports and oversees operational activities related to the non-medical product portfolio under the Office’s organizational structure.
Prior to this role, Ms. Socgfack served as a Policy Analyst in the Office of the Commissioner within OES, where she handled executive-level briefings, correspondence, data calls, RFIs, and cross-cutting meetings, and supported executive leadership.
Before joining the Office of the Commissioner, Ms. Socgfack spent ten years in the Center for Food Safety and Applied Nutrition, now the Human Foods Program (HFP). She served three years as a Supervisory Data Analyst in the Adverse Events Reporting System, overseeing analytical and reporting operations, followed by seven years as a Public Affairs Specialist in the Technical Assistance Network, providing regulatory information and stakeholder support.
Ms. Socgfack holds a Bachelor of Science from the University of Maryland, College Park, School of Public Health; a Master of Business Administration from the University of Maryland; and a Juris Doctor from the University of Baltimore.